These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26982646)

  • 1. [Age-related macular degeneration – a challenge for public health care].
    Mantel I
    Ther Umsch; 2016; 73(2):79-83. PubMed ID: 26982646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-VEGF agents for age-related macular degeneration.
    Ozkiris A
    Expert Opin Ther Pat; 2010 Jan; 20(1):103-18. PubMed ID: 20021287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F; Lafuma A; Berdeaux G
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Age-related macular degeneration].
    Van Bol L; Rasquin F
    Rev Med Brux; 2014 Sep; 35(4):265-70. PubMed ID: 25675629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidance for the treatment of neovascular age-related macular degeneration (AMD)].
    Karska-Basta I; Kubicka-Trzaska A; Oleksy P; Romanowska-Dixon B
    Przegl Lek; 2009; 66(11):972-5. PubMed ID: 20297641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Age related macular degeneration].
    Helgadóttir G; Jónasson F; Sigurdsson H; Magnússon KP; Stefánsson E
    Laeknabladid; 2006 Oct; 92(10):685-96. PubMed ID: 17062902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
    Verma L; Das T; Binder S; Heriot WJ; Kirchhof B; Venkatesh P; Krebs I; Stolba U; Jahn C; Feichtinger H; Kellner L; Krugluger H; Pawelka I; Frohner U; Kruger A; Li W; Tewari HK
    Indian J Ophthalmol; 2000 Dec; 48(4):263-78. PubMed ID: 11340884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age related macular degeneration as a cause of blindness].
    Starzycka M; Słomska J
    Klin Oczna; 1997; 99(4):253-5. PubMed ID: 9577117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.
    Wickremasinghe SS; Michalova K; Gilhotra J; Guymer RH; Harper CA; Wong TY; Qureshi S
    Ophthalmology; 2008 Nov; 115(11):1911-5. PubMed ID: 18672291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance for the treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Richard G; Augustin A; Aylward WG; Bandello F; Corcòstegui B; Cunha-Vaz J; Gaudric A; Leys A; Schlingemann RO;
    Acta Ophthalmol Scand; 2007 Aug; 85(5):486-94. PubMed ID: 17655610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
    Fletcher EC; Lade RJ; Adewoyin T; Chong NV
    Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age related macular degeneration].
    Sayen A; Hubert I; Berrod JP
    Rev Prat; 2011 Feb; 61(2):159-64. PubMed ID: 21618758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapeutic approaches in neovascular age-related macular degeneration.
    Nguyen DH; Luo J; Zhang K; Zhang M
    Discov Med; 2013 Jun; 15(85):343-8. PubMed ID: 23819948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration in Onitsha, Nigeria.
    Nwosu SN
    Niger J Clin Pract; 2011; 14(3):327-31. PubMed ID: 22037079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Related Macular Degeneration.
    Thomas CJ; Mirza RG; Gill MK
    Med Clin North Am; 2021 May; 105(3):473-491. PubMed ID: 33926642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of neovascular age-related macular degeneration.
    Schmidt-Erfurth UM; Pruente C
    Prog Retin Eye Res; 2007 Jul; 26(4):437-51. PubMed ID: 17512238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
    Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
    Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progression of treatment and researches in dry age related macular degeneration].
    Zhang K; Tang S
    Zhonghua Yan Ke Za Zhi; 2015 Mar; 51(3):236-40. PubMed ID: 26268648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.